TheraRadar
← Back
Data updated: Mar 29, 2026

XIROMED

OncologyDermatologyInfectious Disease
Generics

XIROMED is a generic drug manufacturer focused on Oncology, Dermatology, Infectious Disease.

2010
Since
57
Drugs
-
Trials
204
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 33%
4 drugs
Dermatology 25%
3 drugs
Infectious Disease 17%
2 drugs
Cardiovascular 17%
2 drugs
Gastroenterology 8%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...